Intern, Isotope Production at Bristol-Myers Squibb

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

InternshipJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

Pursuing undergraduate/graduate degree in sciences, particularly chemistry, inorganic chemistry, and radiochemistry
Wetlab experience is required
Pipettes, negative pressure glovebox experience, and radioactive material handling preferred but not required
Ion exchange and/or extraction chromatography experience preferred
Strong communication skills
Experience working in highly collaborative environment, ability to work in a team
All candidates must be authorized to work in the US both at the time of hire and for the duration of their employment (no immigration or visa sponsorship available)

Responsibilities

General Laboratory Tasks: Lab Safety Induction & Practice, Sample Preparation
Radiochemical Separation & Production Support: Column Preparation & Operation, Separation Process Monitoring, Assisting with Chemical Separations, Tracer Studies
Analytical & Data Tasks: Sample Analysis, Data Logging & Interpretation, Technical Literature Review
Facility & Regulatory Support: Radiation Survey & Monitoring, Waste Management Support, Documentation & SOP Updates, Contribute to the revision and drafting of standard operating procedures
Project-Oriented Tasks: Design a small experiment investigating a variable in radiochemical separation (e.g., effect of acid concentration on binding efficiency), Present findings to the team at the end of the internship
Process Improvement Challenge: Identify bottlenecks or inefficiencies in lab routines and propose solutions

Skills

Lab Safety

Sample Preparation

Radiochemical Separation

Column Preparation

Column Operation

Chemical Separations

Tracer Studies

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free